UC Study Confirms Safety, Effectiveness of Parkinson’s Pump Treatment

An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an
March 16, 2024
All about the disease
Others have tried and failed to target α-synuclein in Parkinson’s disease, but Roche hopes a Phase II study could deliver success later this year.